BioCentury | Mar 29, 2016
Financial News

Quaker's Gavin passes away

...the S.R. One venture arm of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), and a general partner at EuclidSR Partners. BC...
BioCentury | Jan 31, 2011
Finance

IPO price watch

...Investors include the Singapore government (13.7% pre-IPO stake); Fidelity (10.9%); Versant Ventures (8%); SmallCap (7.5%); EuclidSR Partners...
BioCentury | Dec 6, 2010
Finance

Drip feed for Clarus

...that year. Shareholders include the Singapore government (13% pre-IPO stake); Fidelity (9.1%); Versant Ventures (8.5%); EuclidSR Partners...
BioCentury | Jan 27, 2009
Financial News

Rib-X raises $25 million

...financing round structured as a note. Existing investors Warburg Pincus ; ABS Ventures; Axiom Ventures; EuclidSR Partners...
BioCentury | Jul 23, 2007
Company News

Pfizer management update

...Co.; and Barbara Dalton as VP of PFE's venture investment group, formerly general partner at EuclidSR Partners...
BioCentury | Apr 12, 2006
Financial News

SkinMedica raises $11.2M

...led by new investor Montagu Newhall. Existing investors Domain; Apax; Perseus-Soros Biopharmaceutical Fund; HealthCare Ventures; EuclidSR Partners...
BioCentury | May 9, 2005
Finance

Ebb & Flow

...million and ended 2004 with $14.3 million in cash. Principal stockholders include AIG Global Investment; EuclidSR Partners...
BioCentury | May 17, 2004
Finance

Ebb & Flow

...as of March 31. Principal stockholders include New Enterprise Associates (17.8% prior to the offering); EuclidSR Partners...
BioCentury | Apr 19, 2004
Emerging Company Profile

Corporate Profile

...Dr. Falk Pharma GmbH Number of employees: 70 Funds raised: $90 million Investors: Nomura International; EuclidSR Partners...
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...Abingworth (16.6% prior to IPO); Harvard Private Capital (16.4%); MDS Inc. (10.5%); Brentwood Associates (9.1%); EuclidSR Partners...
Items per page:
1 - 10 of 21
BioCentury | Mar 29, 2016
Financial News

Quaker's Gavin passes away

...the S.R. One venture arm of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), and a general partner at EuclidSR Partners. BC...
BioCentury | Jan 31, 2011
Finance

IPO price watch

...Investors include the Singapore government (13.7% pre-IPO stake); Fidelity (10.9%); Versant Ventures (8%); SmallCap (7.5%); EuclidSR Partners...
BioCentury | Dec 6, 2010
Finance

Drip feed for Clarus

...that year. Shareholders include the Singapore government (13% pre-IPO stake); Fidelity (9.1%); Versant Ventures (8.5%); EuclidSR Partners...
BioCentury | Jan 27, 2009
Financial News

Rib-X raises $25 million

...financing round structured as a note. Existing investors Warburg Pincus ; ABS Ventures; Axiom Ventures; EuclidSR Partners...
BioCentury | Jul 23, 2007
Company News

Pfizer management update

...Co.; and Barbara Dalton as VP of PFE's venture investment group, formerly general partner at EuclidSR Partners...
BioCentury | Apr 12, 2006
Financial News

SkinMedica raises $11.2M

...led by new investor Montagu Newhall. Existing investors Domain; Apax; Perseus-Soros Biopharmaceutical Fund; HealthCare Ventures; EuclidSR Partners...
BioCentury | May 9, 2005
Finance

Ebb & Flow

...million and ended 2004 with $14.3 million in cash. Principal stockholders include AIG Global Investment; EuclidSR Partners...
BioCentury | May 17, 2004
Finance

Ebb & Flow

...as of March 31. Principal stockholders include New Enterprise Associates (17.8% prior to the offering); EuclidSR Partners...
BioCentury | Apr 19, 2004
Emerging Company Profile

Corporate Profile

...Dr. Falk Pharma GmbH Number of employees: 70 Funds raised: $90 million Investors: Nomura International; EuclidSR Partners...
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...Abingworth (16.6% prior to IPO); Harvard Private Capital (16.4%); MDS Inc. (10.5%); Brentwood Associates (9.1%); EuclidSR Partners...
Items per page:
1 - 10 of 21